Introduction:An email circulating from Visibility Nexus references America’s “hottest...

Analysis of Indian Pharmaceutical Market (IPM) – 2024 This data...

IPM Momentum, Innovation Waves & the AQI-Driven Respiratory Surge...

After settling down comfortably into my seat on a flight from Chicago to San Francisco, I started browsing through my digital copy of the latest issue of The Economist. Much to my surprise, I saw an article titled, The Usefulness of Managers beginning with the sentence, "Is your manager really necessary?" Bingo!!! My mind went back to so many discussions we keep having about our Indian Pharma industry and the various arguments about line management and their contributions, role clarity, their usefulness and the often-asked question, “Are they really effective?” When the top leadership says, that effective managers are a rare breed with comments such as, “they are the weakest link in our chain”, my mind keeps racing through with the thought as to, “if they are not, who has to be responsible to make them effective?” Having been a line manager and climbing the ladder against odds, I can understand and empathise with both sides of this management world. However, when these doubts and questions keep raising its head often, my curiosity quotient kept raising a question, “Are we in Indian pharma very unique to have such challenges?” A chance meeting I had with a team of Google senior management personnel based in Google’s headquarters in California during this trip gave me an interesting insight on what Google did and what it continues to do. Much to my solace I found that their apprehensions were similar to what we in Indian Pharma face. The differentiating factor was that their "people operations" team (HR) has applied the Google Way (data analytics) to management analysis and developed a manifesto entitled Eight Habits of Highly Effective Google Managers.

2020 has been a challenging year for all industries. For pharma and its HCP customers even more so. All eyes are on the companies developing vaccines and drugs for treatment of COVID-19, while doctors have closed their doors for pharma reps. Long established processes have been disrupted and complex market strategies have been rendered useless. Each pharma no matter big or small, innovative, or generic, had to improvise and come up with contingency plans to save the year. Some have been slower waiting for the old ways to come back, others have been more agile experimenting with digital and expanding boundaries, most are in the middle digitally curious but not risking too much.

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...

Executive Summary — The Paradox of Scale In the annals...

In India, where urban sleep debt is rising, obesity...

When a new cancer drug shows promise, it trends...

India’s caesarean section debate is drifting toward polarisation. On one...

In big pharma, leadership changes are rarely impulsive. They...